["{\n\"step_by_step_thinking\": \"The patient has a history of myocardial infarction 2 months ago, which makes him susceptible to an acute exacerbation of his cardiac disease when beta-blocker treatment is stopped. The current symptoms are likely related to this previous condition. Beta-adrenergic blocking agents have been widely used in ischemic heart disease and can achieve significant benefits in the secondary prevention of recurrent events in patients following acute myocardial infarction (MI). Therefore, treatment with a Î²-adrenergic blocking agent is most likely to improve the patient's symptoms due to its ability to prevent an acute exacerbation of his cardiac disease.\",\n\"answer_choice\": \"A\"\n}"]